MPN-U patients exhibit lower platelet counts and higher venous thrombosis rates compared to ET, with thrombosis often occurring at atypical sites. Genetic analysis shows JAK2 mutations are more common ...
In patients with MPNs, having at least 1 CVRF was associated with a worse OS. In patients with myeloproliferative neoplasms (MPNs), cardiovascular risk factors (CVRFs) appeared predictive of poorer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results